OUR PRODUCTS

MOBILE APPS

GENERAL INFO

NXTC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

NextCure (NXTC) Earnings Date & Reports

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NXTC is expected to report earnings to fall 96.01% to -44 cents per share on October 30

Q3'25

Est.

$-0.45

Q2'25

Missed

by $10.86

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.08

Q3'24

Missed

by $0.06

The last earnings report on July 31 showed earnings per share of -1128 cents, missing the estimate of -42 cents. With 8.08K shares outstanding, the current market capitalization sits at 13.69M.

View a ticker or compare two or three

Compare

NXTC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NXTC
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NXTC showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9000 Virginia Manor Road

Phone

+1 240 399-4900

Employees

Web

https://www.nextcure.com